What is Evaluate?
Founded in 1996 and headquartered in Greater London, United Kingdom, Evaluate is a prominent provider of pharmaceutical and medical device data. The company excels in collecting, calibrating, and connecting critical data points, offering trusted commercial intelligence to industry stakeholders. Evaluate's comprehensive data solutions empower clients to make informed strategic decisions within the dynamic pharmaceutical and medtech landscapes.
How much funding has Evaluate raised?
Evaluate has raised a total of $10.6M across 1 funding round:
Private Equity
$10.6M
Private Equity (2020): $10.6M with participation from HgCapital Trust
Key Investors in Evaluate
HgCapital Trust
HgCapital Trust is a private equity firm known for its investments in technology and services companies, likely focusing on businesses with strong recurring revenue models and market leadership.
What's next for Evaluate?
With a substantial enterprise-level funding round and a recent major strategic investment, Evaluate is poised for significant expansion. This backing will likely fuel advancements in its data analytics platforms and broaden its market reach. The company's focus on pharmaceutical and medical device intelligence positions it to capitalize on the growing demand for data-driven insights in the healthcare sector. Future developments may include enhanced predictive analytics and deeper integration of real-world evidence.
See full Evaluate company page
